FDA Approves Bristol-Myers Squibb’s Breyanzi as First-Ever CAR T Therapy for Rare Marginal Zone Lymphoma

21 12 月, 2025

One Min Read

31 Views

原文: https://finance.yahoo.com/news/fda-approves-bristol-myers-squibb-155751905.html

Last Update: 21 12 月, 2025

Written By

Other Articles

Previous

Is MercadoLibre (MELI) One of the Best Stocks to Buy for the Next 5 Years?

Next

Cantor Fitzgerald Trims Marvell (MRVL) PT to $100, Cites Neutral Stance Amid AI Expansion

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept